These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 34658899

  • 1. Analysis of M4 Transmembrane Segments in NMDA Receptor Function: A Negative Allosteric Modulatory Site at the GluN1 M4 is Determining the Efficiency of Neurosteroid Modulation.
    Langer K, Müller-Längle A, Wempe J, Laube B.
    Front Pharmacol; 2021; 12():769046. PubMed ID: 34658899
    [Abstract] [Full Text] [Related]

  • 2. Divergent roles of a peripheral transmembrane segment in AMPA and NMDA receptors.
    Amin JB, Salussolia CL, Chan K, Regan MC, Dai J, Zhou HX, Furukawa H, Bowen ME, Wollmuth LP.
    J Gen Physiol; 2017 Jun 05; 149(6):661-680. PubMed ID: 28507080
    [Abstract] [Full Text] [Related]

  • 3. Negative allosteric modulation of GluN1/GluN3 NMDA receptors.
    Zhu Z, Yi F, Epplin MP, Liu D, Summer SL, Mizu R, Shaulsky G, XiangWei W, Tang W, Burger PB, Menaldino DS, Myers SJ, Liotta DC, Hansen KB, Yuan H, Traynelis SF.
    Neuropharmacology; 2020 Oct 01; 176():108117. PubMed ID: 32389749
    [Abstract] [Full Text] [Related]

  • 4. Disruption of S2-M4 linker coupling reveals novel subunit-specific contributions to N-methyl-d-aspartate receptor function and ethanol sensitivity.
    Hughes BA, Woodward JJ.
    Neuropharmacology; 2016 Jun 01; 105():96-105. PubMed ID: 26577016
    [Abstract] [Full Text] [Related]

  • 5. Identification of a Subtype-Selective Allosteric Inhibitor of GluN1/GluN3 NMDA Receptors.
    Zeng Y, Zheng Y, Zhang T, Ye F, Zhan L, Kou Z, Zhu S, Gao Z.
    Front Pharmacol; 2022 Jun 01; 13():888308. PubMed ID: 35754487
    [Abstract] [Full Text] [Related]

  • 6. Structure-based discovery of antagonists for GluN3-containing N-methyl-D-aspartate receptors.
    Kvist T, Greenwood JR, Hansen KB, Traynelis SF, Bräuner-Osborne H.
    Neuropharmacology; 2013 Dec 01; 75():324-36. PubMed ID: 23973313
    [Abstract] [Full Text] [Related]

  • 7. Local constraints in either the GluN1 or GluN2 subunit equally impair NMDA receptor pore opening.
    Talukder I, Wollmuth LP.
    J Gen Physiol; 2011 Aug 01; 138(2):179-94. PubMed ID: 21746848
    [Abstract] [Full Text] [Related]

  • 8. Site of Action of Brain Neurosteroid Pregnenolone Sulfate at the N-Methyl-D-Aspartate Receptor.
    Hrcka Krausova B, Kysilov B, Cerny J, Vyklicky V, Smejkalova T, Ladislav M, Balik A, Korinek M, Chodounska H, Kudova E, Vyklicky L.
    J Neurosci; 2020 Jul 29; 40(31):5922-5936. PubMed ID: 32611707
    [Abstract] [Full Text] [Related]

  • 9. The N-terminal domain of the GluN3A subunit determines the efficacy of glycine-activated NMDA receptors.
    Mesic I, Madry C, Geider K, Bernhard M, Betz H, Laube B.
    Neuropharmacology; 2016 Jun 29; 105():133-141. PubMed ID: 26777280
    [Abstract] [Full Text] [Related]

  • 10. Specific pathogenic mutations in the M3 domain of the GluN1 subunit regulate the surface delivery and pharmacological sensitivity of NMDA receptors.
    Kolcheva M, Kortus S, Krausova BH, Barackova P, Misiachna A, Danacikova S, Kaniakova M, Hemelikova K, Hotovec M, Rehakova K, Horak M.
    Neuropharmacology; 2021 May 15; 189():108528. PubMed ID: 33773999
    [Abstract] [Full Text] [Related]

  • 11. Arrangement of subunits in functional NMDA receptors.
    Salussolia CL, Prodromou ML, Borker P, Wollmuth LP.
    J Neurosci; 2011 Aug 03; 31(31):11295-304. PubMed ID: 21813689
    [Abstract] [Full Text] [Related]

  • 12. Structural insights into assembly and function of GluN1-2C, GluN1-2A-2C, and GluN1-2D NMDARs.
    Chou TH, Kang H, Simorowski N, Traynelis SF, Furukawa H.
    Mol Cell; 2022 Dec 01; 82(23):4548-4563.e4. PubMed ID: 36309015
    [Abstract] [Full Text] [Related]

  • 13. A structurally derived model of subunit-dependent NMDA receptor function.
    Gibb AJ, Ogden KK, McDaniel MJ, Vance KM, Kell SA, Butch C, Burger P, Liotta DC, Traynelis SF.
    J Physiol; 2018 Sep 01; 596(17):4057-4089. PubMed ID: 29917241
    [Abstract] [Full Text] [Related]

  • 14. Glycine agonism in ionotropic glutamate receptors.
    Stroebel D, Mony L, Paoletti P.
    Neuropharmacology; 2021 Aug 01; 193():108631. PubMed ID: 34058193
    [Abstract] [Full Text] [Related]

  • 15. Chimeric Glutamate Receptor Subunits Reveal the Transmembrane Domain Is Sufficient for NMDA Receptor Pore Properties but Some Positive Allosteric Modulators Require Additional Domains.
    Wilding TJ, Lopez MN, Huettner JE.
    J Neurosci; 2016 Aug 24; 36(34):8815-25. PubMed ID: 27559165
    [Abstract] [Full Text] [Related]

  • 16. An alternating GluN1-2-1-2 subunit arrangement in mature NMDA receptors.
    Riou M, Stroebel D, Edwardson JM, Paoletti P.
    PLoS One; 2012 Aug 24; 7(4):e35134. PubMed ID: 22493736
    [Abstract] [Full Text] [Related]

  • 17. Distinct GluN1 and GluN2 Structural Determinants for Subunit-Selective Positive Allosteric Modulation of N-Methyl-d-aspartate Receptors.
    Strong KL, Epplin MP, Ogden KK, Burger PB, Kaiser TM, Wilding TJ, Kusumoto H, Camp CR, Shaulsky G, Bhattacharya S, Perszyk RE, Menaldino DS, McDaniel MJ, Zhang J, Le P, Banke TG, Hansen KB, Huettner JE, Liotta DC, Traynelis SF.
    ACS Chem Neurosci; 2021 Jan 06; 12(1):79-98. PubMed ID: 33326224
    [Abstract] [Full Text] [Related]

  • 18. The LILI Motif of M3-S2 Linkers Is a Component of the NMDA Receptor Channel Gate.
    Ladislav M, Cerny J, Krusek J, Horak M, Balik A, Vyklicky L.
    Front Mol Neurosci; 2018 Jan 06; 11():113. PubMed ID: 29681798
    [Abstract] [Full Text] [Related]

  • 19. Properties of Triheteromeric N-Methyl-d-Aspartate Receptors Containing Two Distinct GluN1 Isoforms.
    Yi F, Zachariassen LG, Dorsett KN, Hansen KB.
    Mol Pharmacol; 2018 May 06; 93(5):453-467. PubMed ID: 29483146
    [Abstract] [Full Text] [Related]

  • 20. Binding of ArgTX-636 in the NMDA receptor ion channel.
    Poulsen MH, Andersen J, Christensen R, Hansen KB, Traynelis SF, Strømgaard K, Kristensen AS.
    J Mol Biol; 2015 Jan 16; 427(1):176-89. PubMed ID: 24862283
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.